Intravitreal bevacizumab: an analysis of the evidence

References

• Abraham-MarinMLCortes-LunaCFAlvarez-RiveraG2006Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot studyGraefes Arch Clin Exp Ophthalmol928[Epub ahead of print]
   Google Scholar
• AdamisAPShimaDTTolentinoMJ1996Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularisation in a nonhuman primateArch Ophthalmol11466718540853
   PubMed Web of Science ®Google Scholar
• AdamisAPShimaDT2005The role of vascular endothelial growth factor in ocular health and diseaseRetina25111815689799
   PubMed Web of Science ®Google Scholar
• AggioFBFarahMEde MeloGB2007Acute endophthalmitis following intravitreal bevacizumab (Avastin) injectionEye21408917277758
   PubMed Web of Science ®Google Scholar
• AggioFBFarahMESilvaWC2006Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatmentsGraefes Arch Clin Exp Ophthalmol121[Epub ahead of print]
   Web of Science ®Google Scholar
• AielloLPAveryRLArriggPG1994Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med331148077526212
   PubMed Web of Science ®Google Scholar
• AisenbreySZiemssenFVolkerM2006Intravitreal bevacizumab (Avastin) for occult neovascularisation in age-related macular degenerationGraefes Arch Clin Exp Ophthalmol1221[Epub ahead of print]
   Google Scholar
• ArevaloJFCarciaRAMendozaAJ2005Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularisation in age-related macular degenerationGraefe’s Arch Clin Exp Ophthalmol24311805
   Web of Science ®Google Scholar
• ArevaloJFFromow-GuerraJQuiroz-MercadoH2007Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-upOphthalmology1147435017398322
   PubMed Web of Science ®Google Scholar
• AveryRLPearlmanJPieramiciDJ2006Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathyOphthalmology113169570517011951
   PubMed Web of Science ®Google Scholar
• AveryRLPieramiciDJRabenaMD2006Intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmology113363372e516458968
   PubMed Web of Science ®Google Scholar
• AveryRL2006Regression of retinal and iris neovascularisation after intravitreal bevacizumab (Avastin) treatmentRetina262798416508427
   PubMed Web of Science ®Google Scholar
• BakriSJDonaldsonMJLinkTP2006Rapid regression of disc neovascularisation in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumabEye201474516680105
   PubMed Web of Science ®Google Scholar
• BashshurZFBazarbachiASchakalA2006Intravitreal bevacizumab for the management of choroidal neovascularisation in age-related macular degenerationAm J Ophthal1421916815245
   PubMed Web of Science ®Google Scholar
• ChanWMLaiTYLiuDT2007Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy or of idiopathic originAm J Ophthalmol423[Epub ahead of print]
   Web of Science ®Google Scholar
• ChenCYWongTYHeriotWJ2007Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term studyAm J Ophthalmol143510217317398
   PubMed Web of Science ®Google Scholar
• ChenEParkCH2006Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathyRetina2669970016829817
   PubMed Web of Science ®Google Scholar
• ChenYWiesmannCFuhG1999Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigenJ Mol Biol2938658110543973
   PubMed Web of Science ®Google Scholar
• ConnolyBPRegilloCDEagleRCJr2003The histopathologic effects of transpupillary thermotherapy in human eyesOphthalmology1104152012578790
   PubMed Web of Science ®Google Scholar
• CostaRAJorgeRCalucciD2006Intravitreal bevacizumab for choroidal neovascularisation caused by AMD (IBeNA Study): results of a phase 1 dose-escalation studyInvest Ophthalmol Vis Sci4745697817003454
   PubMed Web of Science ®Google Scholar
• CostaRAJorgeRCalucciD2007Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO StudyRetina27141917290194
   PubMed Web of Science ®Google Scholar
• CotterSAChuRHChandlerDL2003Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years oldAm J Ophthalmol1366556114516805
   PubMed Web of Science ®Google Scholar
• EmersonMVLauerAKFlaxelCJ2007Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degenerationRetina274394417420695
   PubMed Web of Science ®Google Scholar
• FerraraNHillanKJGerberHP2004Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNat Rev Drug Discov339140015136787
   PubMed Web of Science ®Google Scholar
• FerraraN2004Vascular endothelial growth factor: basic science and clinical progressEndocr Rev2558161115294883
   PubMed Web of Science ®Google Scholar
• FingerPT2007Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathyAm J Ophthalmol143335817258524
   PubMed Web of Science ®Google Scholar
• FolkmanJ1971Tumor angiogenesis: therapeutic implicationsN Engl J Med285118264938153
   PubMed Web of Science ®Google Scholar
• FriedlanderSMWelchRM2006Vanishing disc neovascularisation following intravitreal bevacizumab (Avastin) injectionArch Ophthalmol124136516966642
   PubMedGoogle Scholar
• FunatsuHYamashitaHNakamuraS2006Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular oedemaOphthalmology11329430116406543
   PubMed Web of Science ®Google Scholar
• GiansantiFVirgiliGBiniA2007Intravitreal bevacizumab therapy for choroidal neovascularisation secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical studyEur J Ophthalmol17230717415697
   PubMed Web of Science ®Google Scholar
• GoffMJJohnsonRNMcDonaldHRIntravitreal bevacizumab for previously treated choroidal neovascularisation from age-related macular degenerationRetina27432817420694
   PubMed Web of Science ®Google Scholar
• GomiFNishidaKOshimaY2007Intravitreal bevacizumab for idiopathic choroidal neovascularisation after previous injection with posterior subtenon triamcinoloneAm J Ophthalmol1435071017317397
   PubMed Web of Science ®Google Scholar
• GragoudasESAdamisAPCunninghamETJr2004Pegaptanib for neovascular age-related macular degenerationN Engl J Med35128051615625332
   PubMed Web of Science ®Google Scholar
• GreenbergPBMartidisARogersAH2002Intravitreal triamcinolone acetonide for macular edema due to central retinal vein occlusionBr J Ophthalmol86247811815359
   PubMed Web of Science ®Google Scholar
• HaritoglouCKookDNeubauerA2006Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edemaRetina26999100517151486
   PubMed Web of Science ®Google Scholar
• HolekampNMBouckNVolpertO2002Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularisation due to age-related macular degenerationAm J Ophthalmol134220712140029
   PubMed Web of Science ®Google Scholar
• IlievMEDomigDWolf-SchnurrburschU2006Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucomaAm J Ophthalmol1421054617157590
   PubMed Web of Science ®Google Scholar
• IsaacsTWBarryC2006Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin)Clin Experiment Ophthalmol34802317073910
   PubMed Web of Science ®Google Scholar
• IshibashiTHataYYoshikawaH1997Expression of vascular endothelial growth factor in experimental choroidal neovascularisationGraefes Arch Clin Exp Ophthalmol235159679085111
   PubMed Web of Science ®Google Scholar
• IshidaSUsuiTYamashiroK2003VEGF 164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularisationJ Exp Med198483912900522
   PubMed Web of Science ®Google Scholar
• IturraldeDSpaideRFMeyerleCB2006Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term studyRetina262798416508427
   PubMed Web of Science ®Google Scholar
• JoeresSHeussenFMTreziakT2007Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferationGraefes Arch Clin Exp Ophthalmol417[Epub ahead of print]
   Google Scholar
• JonasJBSpandauUHSchlichtenbredeF2007Intravitreal bevacizumab for filtering surgeryOphthalmic Res39121217284939
   PubMed Web of Science ®Google Scholar
• JorgeRCostaRACalucciD2006Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)Retina2610061317151487
   PubMed Web of Science ®Google Scholar
• JorgeRCostaRACalucciD2006Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularisation in idiopathic juxtafoveolar retinal telangiectasisGraefes Arch Clin Exp Ophthalmol1129 [Epub ahead of print]
   Google Scholar
• KahookMYSchumanJSNoeckerRJ2006Intravitreal bevacizumab in a patient with neovascular glaucomaOphthalmic Surg Lasers Imaging37144616583637
   PubMedGoogle Scholar
• KumarASinhaS2007Rapid regression of disc and retinal neovascularisation in a case of Eales disease after intravitreal bevacizumabCan J Ophthalmol42335617392871
   PubMed Web of Science ®Google Scholar
• LaudKSpaideRFFreundKB2006Treatment of choroidal neovascularisation in pathologic myopia with intravitreal bevacizumabRetina26960317031300
   PubMed Web of Science ®Google Scholar
• LazicRGabricN2007Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularisation secondary to age-related macular degenerationGraefes Arch Clin Exp Ophthalmol245687317111146
   PubMed Web of Science ®Google Scholar
• [MPSG] Macular Photocoagulation Study Group1991Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trialsArch Ophthalmol1091109141714270
   PubMedGoogle Scholar
• MasonJO3rdAlbertMAJrMaysA2006Regression of neovascular iris vessels by intravitreal injection of bevacizumabRetina26
   Web of Science ®Google Scholar
• MasonJO3rdAlbertMAJrVailR2006Intravitreal bevacizumab (Avastin) for refractory pseudophakic macular edemaRetina26356716508440
   PubMed Web of Science ®Google Scholar
• MasonJO3rdNixonPAWhiteMF2006Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathyAm J Ophthalmol142685817011869
   PubMed Web of Science ®Google Scholar
• MatsumotoYFreundKBPeirettiE2007Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive diseaseRetina274263117420693
   PubMed Web of Science ®Google Scholar
• MeloGBFarahMEAggioFB2007Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosaActa Ophthalmol Scand219 [Epub ahead of print]
   Google Scholar
• MeyerCHMennelSSchmidtJC2006Acute retinal epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degenerationBr J Ophthalmol901207816929069
   PubMed Web of Science ®Google Scholar
• MeyerleCBFreundKBIturraldeD2007Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferationRetina27451717420697
   PubMed Web of Science ®Google Scholar
• MichaelsonIC1948The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseasesTrans Ophthalmol Soc UK68
   Google Scholar
• MichelsSRosenfeldPJPuliafitoCA2005Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twelve-week results of an uncontrolled open-label clinical studyOphthalmology11210354715936441
   PubMed Web of Science ®Google Scholar
• MoonSJBergerASTolentinoMJ2007Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasisOphthalmic Surg Lasers Imaging38164617396701
   PubMedGoogle Scholar
• MoschosMMBrouzasEApostolopoulosM2007Intravitreal use of bevacizumab (Avastin) for choroidal neovascularisation due to ARMD: a preliminary multifocal-ERG and OCT study: Multifocal ERG after use of bevacizumab in ARMDDoc Ophthalmol114374417216267
   PubMed Web of Science ®Google Scholar
• MoshfeghiAARosenfeldPJPuliafitoCA2006Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twenty four-week results of an uncontrolled open-label clinical studyOphthalmology11320021117027972
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSTatlipinarS2005Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia (letter)Br J Ophthalmol8913687016170134
   PubMed Web of Science ®Google Scholar
• NicoloMGhiglioneDCalabriaG2006Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin)Eur J Ophthalmol16770317061236
   PubMed Web of Science ®Google Scholar
• OshimaYSakaguchiHGomiF2006Regression of iris neovascularisation after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathyAm J Ophthalmol142155816815267
   PubMed Web of Science ®Google Scholar
• OtaniATakagiHOhH1999Expressions of angiopoietins and Tie2 in human choroidal neovascular membranesInvest Ophthalmol Vis Sci4019122010440243
   PubMed Web of Science ®Google Scholar
• PaiSAShettyRVijayanPB2007Clinical, anatomic and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusionAm J Ophthalmol143601617306753
   PubMed Web of Science ®Google Scholar
• ParkCHJaffeGJFekratS2003Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusionAm J Ophthalmol136
   Web of Science ®Google Scholar
• PaulaJSJorgeRCostaRA2006Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularisation in neovascular glaucomaActa Ophthalmol Scand84556716879583
   PubMedGoogle Scholar
• PieramiciDJAveryRLCastellarinAA2006Case of anterior uveitis after intravitreal injection of bevacizumabRetina26841216963867
   PubMed Web of Science ®Google Scholar
• RabenaMDPieramiciDJCastellarinAA2007Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusionRetina274192517420692
   PubMed Web of Science ®Google Scholar
• RichRMRosenfeldPJPuliafitoCA2006Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRetina2649551116770255
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJS2006Ranibizumab for Neovascular Age-Related Macular DegenerationN Engl J Med35514324417021319
   PubMed Web of Science ®Google Scholar
• RosenfeldPJFungAEPuliafitoCA2005Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusionOphthalmic Surg Lasers Imaging36336916156153
   PubMed Web of Science ®Google Scholar
• RosenfeldPJMoshfeghiAAPuliafitoCA2005Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging36331516156152
   PubMed Web of Science ®Google Scholar
• SakaguchiHIkunoYGomiF2006Intravitreal injection of bevacizumab for choroidal neovascularisation caused by pathological myopiaBr J Ophthalmol816 [Epub ahead of print]
   Google Scholar
• SchlingemannRO2004Role of growth factors and the wound healing response in age-related macular degenerationGraefes Arch Clin Exp Ophthalmol2429110114685874
   PubMed Web of Science ®Google Scholar
• SchwartzSGHickeyMPuliafitoCA2006Bilateral CRAO and CRVO from thrombotic thrombocytopenic purpura: OCT findings and treatment with triamcinolone acetonide and bevacizumabOphthalmic Surg Lasers Imaging37420217017202
   PubMed Web of Science ®Google Scholar
• ShahCPHsuJGargSJ2006Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degenerationAm J Ophthalmol14210687017157597
   PubMed Web of Science ®Google Scholar
• ShahMAIlsonDKelsenDP2005Thrombo-embolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapyJ Clin Oncol232574615795413
   PubMed Web of Science ®Google Scholar
• ShahPKNarendranVTawansyKA2007Intravitreal bevacizumab (Avastin) for post laser anterior segment ischaemia in aggressive posterior retinopathy of prematurityIndian J Ophthalmol5575617189897
   PubMedGoogle Scholar
• SiqueiraRCCostaRAScottIU2006Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularisation caused by sickle cell retinopathyActa Ophthalmol Scand84834517083555
   PubMedGoogle Scholar
• SolimanWLund-AndersenHLarsenM2006Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularisationActa Ophthalmol Scand84707816965507
   PubMedGoogle Scholar
• SpaideRFFisherYL2006Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous haemorrhageRetina26275816508426
   PubMed Web of Science ®Google Scholar
• SpaideRFLaudKFineHF2006Intravitreal bevacizumab treatment for choroidal neovascularisation secondary to age-related macular degenerationRetina263839016603955
   PubMed Web of Science ®Google Scholar
• SpandauUHIhloffAKJonasJB2006Intravitreal bevacizumab treatment of macular edema due to central retinal vein occlusionActa Ophthalmol Scand84555616879582
   PubMedGoogle Scholar
• [TAP] Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group1999Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials – TAP report 1Arch Ophthalmol11713294510532441
   PubMedGoogle Scholar
• TeixeiraAMoraesNFarahME2006Choroidal neovascularisation treated with intravitreal injection of bevacizumab (Avastin) in angioid streaksActa Ophthalmol Scand84835617083556
   PubMedGoogle Scholar
• TewariADhallaMSApteRS2006Intravitreal bevacizumab for treatment of choroidal neovascularisation in pathologic myopiaRetina261093417151505
   PubMed Web of Science ®Google Scholar
• TolentinoMJMcLeodDSTaomotoM2002Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primateAm J Ophthalmol1333738511860975
   PubMed Web of Science ®Google Scholar
• TolentinoMJMillerJWGragoudasES1996Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primateOphthalmology103182088942877
   PubMed Web of Science ®Google Scholar
• TolentinoMJMillerJWGragoudasES1996Vascular endothelial growth factor is sufficient to produce iris neovascularisation and neovascular glaucoma in a nonhuman primateArch Ophthalmol114964708694732
   PubMed Web of Science ®Google Scholar
• [VIP] Verteporfin in Photodynamic Therapy (VIP) Study Group2001Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization – VIP report 2Am J Ophthalmol1315416011336929
   PubMed Web of Science ®Google Scholar
• [VIP] Verteporfin in Photodynamic Therapy (VIP) Study Group2003Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial – VIP report no 3Ophthalmology1106677312689884
   PubMed Web of Science ®Google Scholar
• VatavukZBencicGMandicZ2007Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusionEur J Ophthalmol172697117415704
   PubMed Web of Science ®Google Scholar
• YamamotoIRogersAHReichelE2006Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathologic myopiaBr J Ophthalmol726 [Epub ahead of print]
   Google Scholar
• YoganathanPDeramoVALaiJC2006Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degenerationRetina26994817151485
   PubMed Web of Science ®Google Scholar
• ZiemssenFDeuterCMStuebigerN2007Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin)Graefes Arch Clin Exp Ophthalmol112 [Epub ahead of print]
   Google Scholar
• ZiemssenFVoelkerMAltpeterE2007Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanomaActa Ophthalmol Scand226 [Epub ahead of print]
   Google Scholar